Aldeyra Therapeutics, Inc. (ALDX) analyst actions
ALDX analyst actions moved a median of +1.60% by the close. Rating and price-target actions on ALDX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ALDX overview →
11 measured ALDX analyst action events.
| Middle 50% of ALDX analyst action reactions | +1.09% to +5.45% |
|---|---|
| Median reaction (to close) | +1.60% |
| Measured reactions | 11 |
Half of the 11 ALDX analyst action events with a measured close landed between +1.09% and +5.45%; 82% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | +0.55% | +4.90% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Reach Out | Press release | +1.07% | +8.34% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | -0.33% | +1.97% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Reach Out | Press release | +0.00% | +1.60% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | +0.88% | +0.00% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Reach Out | Press release | +0.89% | +1.33% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | +0.00% | +0.85% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | -1.66% | -11.58% | |
| ALDX NOTICE: A Securities Investigation was initiated on behalf of Aldeyra Therapeutics, Inc. Investors - Contact BFA Law | Press release | -0.19% | +1.34% | |
| ALDX CLASS NOTICE: An Investigation has been Initiated on behalf of Aldeyra Therapeutics, Inc. Investors -- Contact BFA Law if You Lost Money (NASDAQ:ALDX) | Press release | -1.09% | +6.01% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out | Press release | +13.03% | +33.10% |
More ALDX: earnings → · SEC filings → · ALDX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| HEMISPHERX BIOPHARMA (HEB) | 779 | -0.06% | 42% |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | 777 | -0.09% | 47% |
| CYTORI THERAPEUTICS (CYTX) | 774 | -0.72% | 32% |
| Adamis Pharmaceuticals Corporation (ADMP) | 772 | -0.47% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.